Tower Research Capital LLC (Trc) Iovance Biotherapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 44,390 shares of IOVA stock, worth $158,028. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,390
Previous 23,233
91.06%
Holding current value
$158,028
Previous $218,000
50.46%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding IOVA
# of Institutions
342Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$98 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$86.9 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$78.7 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$75.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$43.6 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $562M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...